Clinical trial
Detection of Multimodal Biomarkers of Electroconvulsive Therapie in Severe and Treatment-resistent Depression
NCT05463562 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Multimodal Biomarkers of Electroconvulsive Therapie in Severe and Treatment-resistent Depression
- Lead sponsor
- Max-Planck-Institute of Psychiatry
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 24, 2022
- Completion date
- February 23, 2025
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.